While obesity may be a fast-growing cost area, it's far from the largest -- only 10% of employers surveyed put it in their ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...

Spyre Therapeutics’ hopes for its anti-TL1A antibody SPY072 in rheumatoid arthritis (RA) have hit a bump in the road after ...

Melbourne, Australia-based biotech Entropy Neurodynamics has signed a Pre-Clinical Trial Agreement (Pre-CTA) with the ...

Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...

Revolution Medicines' Rasonque (daraxonrasib), the RAS inhibitor that received a standing ovation at ASCO for its doubling of overall survival in patients with metastatic pancreatic ductal ...

A year after officially launching its AI agency offering, EVERSANA is expanding the platform’s capabilities and announcing a ...

Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital ...

Roche has won US FDA clearance for a blood test that could move Alzheimer’s biomarker testing further into primary care, ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

The US FDA announced two De Novo marketing authorisations for novel medical devices this week: A continuous glucose monitor ...